These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25953642)

  • 1. What a pain.
    Drug Ther Bull; 2015 May; 53(5):49. PubMed ID: 25953642
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregabalin: what the patent litigation means for doctors and drug companies.
    Smyth D; Croker R; Goldacre B
    BMJ; 2018 Jun; 361():k2318. PubMed ID: 29880536
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion from thrice- to twice-daily pregabalin dosing for pain: Economic and clinical outcomes in a veteran population.
    Okolo C; Malmstrom R; Duncan K; Lopez J
    Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S74-8. PubMed ID: 26272896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin.
    Sicras-Mainar A; Rejas-Gutiérrez J; Pérez-Paramo M; Sánchez-Alvarez L; Navarro-Artieda R; Darbà J
    Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):45-57. PubMed ID: 30182806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of treating peripheral neuropathic pain with pregabalin or gabapentin at therapeutic doses in routine practice.
    Sicras-Mainar A; Rejas-Gutiérrez J; Perez-Paramo M; Navarro-Artieda R
    J Comp Eff Res; 2018 Jul; 7(7):615-625. PubMed ID: 29754518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of pregabalin and gabapentin in palliative care #289.
    Pruskowski J; Arnold RM
    J Palliat Med; 2015 Apr; 18(4):386-7. PubMed ID: 25714108
    [No Abstract]   [Full Text] [Related]  

  • 7. A cost-utility analysis of pregabalin in the management of peripheral neuropathic pain.
    Annemans L; Caekelbergh K; Morlion B; Hans G; De Cock P; Marbaix S
    Acta Clin Belg; 2008; 63(3):170-8. PubMed ID: 18714847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-consequences analysis of the effect of pregabalin in the treatment of painful radiculopathy under medical practice conditions in primary care settings.
    Saldaña MT; Navarro A; Pérez C; Masramón X; Rejas J
    Pain Pract; 2010; 10(1):31-41. PubMed ID: 20629966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pfizer could owe NHS £500m for extending pregabalin patent for pain.
    Hawkes N
    BMJ; 2018 Nov; 363():k4856. PubMed ID: 30442646
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of drug-resistant chronic cluster headache who response pregabalin].
    Akpınar ÇK; Erdoğan S
    Agri; 2016 Apr; 28(2):119. PubMed ID: 27225744
    [No Abstract]   [Full Text] [Related]  

  • 11. Pfizer loses appeal over use of branded painkiller pregabalin.
    Hawkes N
    BMJ; 2016 Oct; 355():i5578. PubMed ID: 27754840
    [No Abstract]   [Full Text] [Related]  

  • 12. A case report: indomethacin resistance hemicrania continua or a new entity?
    Coşkun O; Uçler S; Ocal R; Inan LE
    Agri; 2014; 26(3):138-40. PubMed ID: 25205413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a Single-Dose of Pre-Emptive Pregabalin on Postoperative Pain and Opioid Consumption After Double-Jaw Surgery: A Randomized Controlled Trial.
    Ahiskalioglu A; İnce İ; Aksoy M; Yalcin E; Ahiskalioglu EO; Kilinc A
    J Oral Maxillofac Surg; 2016 Jan; 74(1):53.e1-7. PubMed ID: 26433040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study.
    Pérez C; Navarro A; Saldaña MT; Masramón X; Rejas J
    Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain therapeutics-SMi Conference. 11-12 June, 2003, London, UK.
    De la Rue S
    IDrugs; 2003 Jul; 6(7):652-5. PubMed ID: 12906016
    [No Abstract]   [Full Text] [Related]  

  • 16. An economic evaluation of pregabalin versus usual care in the management of community-treated patients with refractory painful diabetic peripheral neuropathy in primary care settings.
    de Salas-Cansado M; Pérez C; Saldaña MT; Navarro A; González-Gómez FJ; Ruiz L; Rejas J
    Prim Care Diabetes; 2012 Dec; 6(4):303-12. PubMed ID: 22595032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin Does Not Decrease the Pain of Sciatica.
    Ebell MH
    Am Fam Physician; 2017 Aug; 96(4):260. PubMed ID: 28925674
    [No Abstract]   [Full Text] [Related]  

  • 18. Pregabalin is only partially effective for neuropathic pain.
    Gwynn J
    BMJ; 2015 Jun; 350():h3478. PubMed ID: 26126622
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary: the paradox of analgesic medication elimination.
    Hooten WM
    Pain Med; 2009; 10(5):797-8. PubMed ID: 19594843
    [No Abstract]   [Full Text] [Related]  

  • 20. Generic drug companies are the winners.
    Voth AJ
    CMAJ; 1991 Nov; 145(9):1081. PubMed ID: 1751924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.